Impact of Organ Donor Pretreatment With Anti-Thymocyte Globulin in a Murine Model of Allogenic Kidney Transplantation
Kidney transplantation is the treatment of choice for end-stage organ failure. To improve transplantation outcomes, particularly of “marginal” organs from extended criteria donors (ECD), attempts have been made to therapeutically modulate donor or graft pre-transplantation. Anti-thymocyte globulin (...
Saved in:
Main Authors: | An He, Yiren Yang, Katja Kotsch, Arne Sattler |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Transplant International |
Subjects: | |
Online Access: | https://www.frontierspartnerships.org/articles/10.3389/ti.2024.13997/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti T-lymphocyte Globulin (Grafalon®) Use during Rabbit Anti-thymocyte Globulin (Thymoglobulin®) Shortage – A Single-center Experience
by: Shailendra Tiwari, et al.
Published: (2024-12-01) -
Evaluating non-utilization of deceased donor kidneys in Korea
by: Suhyun Oh, et al.
Published: (2025-01-01) -
Evaluation of deceased-donor kidney offers: development and validation of novel data driven and expert based prediction models for early transplant outcomes
by: Christoph F. Mahler, et al.
Published: (2025-01-01) -
Hyperspectral imaging in living and deceased donor kidney transplantation
by: Rasmus Wrigge, et al.
Published: (2025-01-01) -
Value of original and modified pathological scoring systems for prognostic prediction in paraffin-embedded donor kidney core biopsy
by: Jinghong Tan, et al.
Published: (2024-12-01)